Loading chat...
IL SB1746
Bill
Status
2/5/2025
Primary Sponsor
Cristina Castro
Click for details
AI Summary
-
Health benefit plans amended, delivered, issued, or renewed on or after January 1, 2026 are prohibited from requiring enrollees to obtain clinician-administered drugs from a pharmacy selected by the insurer or pharmacy benefit manager
-
Insurers and pharmacy benefit managers cannot steer patients through financial incentives, impose higher cost-sharing, or deny coverage for clinician-administered drugs obtained from the administering provider or a non-designated pharmacy
-
Plans cannot require home infusion or specific sites of service for clinician-administered drugs, nor include site of service in prior authorization or medical necessity criteria
-
Clinician-administered drugs must comply with federal Drug Supply Chain Security Act requirements for supply chain security and chain of distribution
-
The requirements apply to state employee group insurance, county and municipal self-insured plans, school district health coverage, health maintenance organizations, and voluntary health services plans
Legislative Description
INS-CLINICIAN ADMINISTER DRUG
Last Action
Rule 3-9(a) / Re-referred to Assignments
4/11/2025